Tyrosinemia a rare genetic metabolic disorder
Information for patients family supporters
Worldwide research for improved treatment
previous arrow
next arrow

The Foundation

TYROSINEMIA FOUNDATION

Our aim is to raise funds for research into the rare metabolic disease Tyrosinemia.
Although life expectancy has been greatly increased since the introduction of the drug Nitisinone, further research is necessary to improve the quality of life of patients.

More about the Tyrosinemia Foundation

 Tyrosinemia Type 1

Without treatment, patients die. To survive, they need a low-protein diet, medication and nutritional supplements.

Tyrosinemia type 1 is a rare, inborn metabolic error disease. With metabolism, the nutrients are in charge and toxins are disposed of. Enzymes are very important in this process. If something is wrong with an enzyme, it accumulates in the body and there is a metabolic disease.

More about Tyrosinemia Type 1

Research

Is necessary and costly

we finance
research of the  rare metabolic disease tyrosinemia type 1 to improve 
the quality of life

More about research

EXPERIENCES

Some personal stories of people with Tyrosinemia

Contact

Do you want to stay informed about the foundation?

 

Do you have a question or a comment?

 

We'd love to hear from you!

 

Send us a message or call/ WhatsApp on +31 654 74 88 08

     



    (*)Required
    Top